Steatorrhea classification: Difference between revisions
Jump to navigation
Jump to search
Sunny Kumar (talk | contribs) No edit summary |
Aditya Ganti (talk | contribs) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} ; {{AE}} {{Vbe}} {{SKA}} | {{CMG}} ; {{AE}} {{Vbe}} {{SKA}} | ||
==Overview== | ==Overview== | ||
Steatorrhea may be classified based on etiology into | Steatorrhea may be classified based on etiology into 3 types, intestinal, biliary, and pancreatic steatorrhea. | ||
==Classification== | ==Classification== | ||
Steatorrhea may be classified based on etiology into | Steatorrhea may be classified based on etiology into 3 types, intestinal, biliary, and pancreatic steatorrhea.<ref name="pmid29085272">{{cite journal| author=Kumar R, Bhargava A, Jaiswal G| title=A case report on total pancreatic lipomatosis: An unusual entity. | journal=Int J Health Sci (Qassim) | year= 2017 | volume= 11 | issue= 4 | pages= 71-73 | pmid=29085272 | doi= | pmc=5654180 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29085272 }}</ref><ref name="pmid28698280">{{cite journal| author=Previti E, Salinari S, Bertuzzi A, Capristo E, Bornstein S, Mingrone G| title=Glycemic control after metabolic surgery: a Granger causality and graph analysis. | journal=Am J Physiol Endocrinol Metab | year= 2017 | volume= 313 | issue= 5 | pages= E622-E630 | pmid=28698280 | doi=10.1152/ajpendo.00042.2017 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28698280 }}</ref><ref name="pmid28281512">{{cite journal| author=Vakhrushev YM, Lukashevich AP| title=[Specific features of impaired intestinal digestion, absorption, and microbiocenosis in patients with cholelithiasis]. | journal=Ter Arkh | year= 2017 | volume= 89 | issue= 2 | pages= 28-32 | pmid=28281512 | doi=10.17116/terarkh201789228-32 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28281512 }}</ref><ref name="pmid27825371">{{cite journal| author=Scarpignato C, Gatta L, Zullo A, Blandizzi C, SIF-AIGO-FIMMG Group. Italian Society of Pharmacology, the Italian Association of Hospital Gastroenterologists, and the Italian Federation of General Practitioners| title=Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. | journal=BMC Med | year= 2016 | volume= 14 | issue= 1 | pages= 179 | pmid=27825371 | doi=10.1186/s12916-016-0718-z | pmc=5101793 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27825371 }}</ref> | ||
* Intestinal causes: | * Intestinal causes: | ||
** [[Infection|Infections]] | ** [[Infection|Infections]] | ||
Latest revision as of 14:17, 12 February 2018
|
Steatorrhea Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Steatorrhea classification On the Web |
|
American Roentgen Ray Society Images of Steatorrhea classification |
|
Risk calculators and risk factors for Steatorrhea classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2] Sunny Kumar MD [3]
Overview
Steatorrhea may be classified based on etiology into 3 types, intestinal, biliary, and pancreatic steatorrhea.
Classification
Steatorrhea may be classified based on etiology into 3 types, intestinal, biliary, and pancreatic steatorrhea.[1][2][3][4]
- Intestinal causes:
- Biliary tract causes:
- Biliary atresia
- Biliary Stricture
- Tumor of biliary tract
- Gallbladder stones
- Pancreatic causes:
- Congenital lipase enzymes deficiency
- Cystic fibrosis
- Inflammation of pancreas
- Pancreatic tumors
References
- ↑ Kumar R, Bhargava A, Jaiswal G (2017). "A case report on total pancreatic lipomatosis: An unusual entity". Int J Health Sci (Qassim). 11 (4): 71–73. PMC 5654180. PMID 29085272.
- ↑ Previti E, Salinari S, Bertuzzi A, Capristo E, Bornstein S, Mingrone G (2017). "Glycemic control after metabolic surgery: a Granger causality and graph analysis". Am J Physiol Endocrinol Metab. 313 (5): E622–E630. doi:10.1152/ajpendo.00042.2017. PMID 28698280.
- ↑ Vakhrushev YM, Lukashevich AP (2017). "[Specific features of impaired intestinal digestion, absorption, and microbiocenosis in patients with cholelithiasis]". Ter Arkh. 89 (2): 28–32. doi:10.17116/terarkh201789228-32. PMID 28281512.
- ↑ Scarpignato C, Gatta L, Zullo A, Blandizzi C, SIF-AIGO-FIMMG Group. Italian Society of Pharmacology, the Italian Association of Hospital Gastroenterologists, and the Italian Federation of General Practitioners (2016). "Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression". BMC Med. 14 (1): 179. doi:10.1186/s12916-016-0718-z. PMC 5101793. PMID 27825371.